BerGenBio has raised $9.5M across 1 funding round on record, the most recent a Post-IPO Debt of $9.5M announced in Oct 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BerGenBio Company Profile and Key Stats
Latest funding round on record: Oct 2022.
BerGenBio Funding Rounds
BerGenBio Founders and Leadership Team
Contact details for the BerGenBio team: 1 of 1 has an email address on file.
Start 14-day free trial →BerGenBio Funding Compared to Other Biotechnology Startups
BerGenBio's latest round of $9.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BerGenBio in Biotechnology and Bergen
Companies Similar to BerGenBio
Zelluna Immunotherapy AS is a privately owned Norwegian biopharmaceutical company founded in 2016 focused on…
Hofseth BioCare's key goal is to offer high benefit added biomarine elements for human applications. Through…
Circio Holding ASA is a company in the clinical stage that is developing immune activators for challenging…
IDEX, a biometrics software and fingerprint authentication company based in Oslo, Norway, was established in…
Arctic Bioscience is a biotechnology research company that develops products, solutions, and technologies…
Lytix Biopharma AS is a privately-owned pharmaceutical company focussed on anti-microbials and cancer…
Actithera is a company specializing in developing radioligand therapies through the application of medicinal…
NoMy is a company focused on creating sustainable and scalable solutions for alternative proteins by…
Oncoinvent AS designs and develops cancer treatments by applying known physical and chemical principles of…
Biosergen AS develops variants of nystatin with improved properties. Its pipeline products include S44HP, an…
NEXT offers secure and user-friendly fingerprint sensor technology for verification purposes in various…
We are a speciality pharmaceutical business committed to the creation and marketing of goods for people who…
BerGenBio Funding FAQs
How much funding has BerGenBio raised?
BerGenBio has raised $9.5M across 1 round on record. The most recent is a Post-IPO Debt of $9.5M announced in Oct 2022.
When did BerGenBio last raise funding?
BerGenBio's most recent funding round on record is a Post-IPO Debt of $9.5M, announced in Oct 2022.
Who is the CEO of BerGenBio?
Richard Godfrey is listed as CEO at BerGenBio.
Where is BerGenBio headquartered?
BerGenBio is based in Bergen, Hordaland, Norway.
How many employees does BerGenBio have?
BerGenBio is in the 11-50 employee band.
How does BerGenBio's funding compare to other Biotechnology startups?
BerGenBio's latest round of $9.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's BerGenBio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BerGenBio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.